Cambridge Healthtech Institute’s 13th Annual
Enabling Precision Oncology for Diagnostic and Drug Development
MARCH 6 - 7, 2023 ALL TIMES PST
Liquid biopsy is a maturing technology for early detection of disease, patient stratification and therapy selection, monitoring response to therapy, and detecting disease recurrence. Cambridge Healthtech Institute’s 13th Annual Liquid Biopsy meeting
will explore the latest technologies in detection and molecular characterization of CTCs, cell-free circulating tumor DNA (cfDNA) and circulating extracellular RNA, exosomes and microvesicles, as well as the applications of liquid biopsy in diagnostics
and drug development.